Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines
Completed · Phase 2
Conditions studied: Glabellar Frown Lines
In brief
The purpose of this study is to demonstrate the safety of multiple doses of DWP-450 (Botulinum purified neurotoxin, Type A) Injection in treatment of moderate to severe glabellar lines in adult subjects.
Key facts
- Study ID
- NCT02184988
- Run by
- Evolus, Inc.
- People needed
- 352
- Starts
- 2014-08-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2019-04-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- ATS Clinical Research — Santa Monica, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.